MoneyWorks4Me

USFDA completes inspection at Solara Active Pharma’s Chennai facility

15 Dec 2018 Evaluate

Solara Active Pharma Science has successfully completed the US Food and Drug Administration’s (USFDA) inspection at Solara Research Centre (SRC), Chennai with zero 483s inspectional observations.

The centre is equipped with high-end infrastructure with advanced analytical capabilities, strong IP assessment skills and global regulatory expertise. SRC is also an important pivot in Solara's Contract Research and manufacturing services (CRAMS) vertical.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1848.40
Dr. Reddys Labs. 1200.90
Cipla 1404.05
Lupin 2083.80
Zydus Lifesciences 1198.95
View more..